Sjogren's Syndrome: all 381 studies
Page 1 of 4. Open to participants first (106), then studies with results posted, then the rest; newest registration first within each.
- A Study of BMS-986553 in Participants With Refractory Autoimmune DiseasesNot yet recruitingNCT07873931Phase 1
- Effectiveness of an Oral Exercise Program for Xerostomia in Patients With Sjögren DiseaseNot yet recruitingNCT07864987Not applicable
- Exploratory Study of the Efficacy of HuMoSCs (Human Monocyte-derived Suppressor Cells) on Glandular Involvement in Sjögren's SyndromeNot yet recruitingNCT07861828Not applicable
- Clinical Efficacy of Telitacicept in Sjögren's Disease With Interstitial Lung DiseaseRecruitingNCT07843381
- Exosome and Mesenchymal Stem Cell Treatment for Salivary Gland Dysfunction in Primary Sjögren SyndromeNot yet recruitingNCT07838454Phase 2
- A Study of IBI355 in Participants With Moderate-to-Severe Sjögren's DiseaseNot yet recruitingNCT07836660Phase 2
- Pain Phenotyping of Rheumatic Diseases - An Observational StudyNot yet recruitingNCT07829497
- ONO-4915 in Patients With Primary Sjogren's DiseaseNot yet recruitingNCT07823790Phase 2
- Ocular Surface Changes and Meibomian Gland Dysfunction in Rheumatologic PatientsNot yet recruitingNCT07810569
- Continued Access to Deucravacitinib for Adult SLE/SjD and Pediatric PsO/PsA Study CompletersNot yet recruitingNCT07791199Phase 3
- A Phase 2a/b Study to Assess the Efficacy, Safety and Tolerability of DDY391 in Participants With Sjögren's DiseaseRecruitingNCT07737743Phase 2
- Sjogren's Mini-Pill Oral and Gut Microbiome StudyNot yet recruitingNCT07732582Not applicable
- A Study of ATG-201 in Adult Participants With Autoimmune DiseasesNot yet recruitingNCT07732309Phase 1
- A Phase 1, First-in-Human Study of CND319 in Healthy Participants and Patients With Rheumatic DiseasesRecruitingNCT07712939Phase 1
- Safety and Efficacy of Topical Infliximab in Autoimmune Dry Eye DiseaseNot yet recruitingNCT07671222Phase 2
- A Trial in Healthy Adult Participants and Adults With Autoimmune Disease to Test How HBM7020 is Tolerated and Absorbed in the BodyRecruitingNCT07649265Phase 1
- Two Arm, Double-blind, Phase III Study Assessing Efficacy and Safety of Ianalumab Versus Placebo, in Participants With Sjögren's Disease With High Symptom BurdenRecruitingNCT07621809Phase 3
- CD19/BCMA-Targeted Universal CAR-T Cell Injection for the Treatment of Autoimmune DiseasesNot yet recruitingNCT07596680Early Phase 1
- Explanatory Factors and Predictors of Fatigue in Patients With Sjögren's Disease: A 3-month Longitudinal StudyRecruitingNCT07544394
- MTS109 in Patients With Refractory Autoimmune DiseasesRecruitingNCT07526350Early Phase 1
- YTS109 in Pediatric Relapsed/Refractory Autoimmune DiseasesNot yet recruitingNCT07439029Phase 1
- A Clinical Study of TI-0032-III Injection in Patients With Relapsed and Refractory Autoimmune DiseasesRecruitingNCT07413341Phase 1
- Phase 3 Study of Telitacicept in Active Primary Sjögren's DiseaseRecruitingNCT07404865Phase 3
- A Study of GSK5926371 in Participants With B-cell Driven Autoimmune Rheumatic Diseases (ARD)RecruitingNCT07371468Phase 1
- Generative AI Impact on Rheumatoid Arthritis Complications DiagnosisRecruitingNCT07301892
- Clinical Study of BCT301 Cell Injection Therapy for Refractory Autoimmune DiseasesRecruitingNCT07301164Early Phase 1
- Repeated Mesenchymal Stem Cell Therapy for Radiation-Induced Hyposalivation and Xerostomia in Head and Neck Cancer SurvivorsNot yet recruitingNCT07290946Phase 2
- A Phase 1 Open-label Study to Evaluate Safety in Healthy Participants and Participants With Autoimmune DiseasesRecruitingNCT07284797Phase 1
- Safety of Tofacitinib, an Oral Janus Kinase Inhibitor, in Primary Sjogren DiseaseRecruitingNCT07281456Phase 2
- Interferon Signature in Anti-CTLA-4 and Anti-PD-1/PD-L1-Treated Cancer Patients Compared With Systemic Autoimmune Disease PatientsRecruitingNCT07249060
- Managed Access Programs for VAY736, IanalumabAvailableNCT07244289
- Exploratory Clinical Study on YTS109 Cell Therapy for Autoimmune DiseasesRecruitingNCT07236801Phase 1
- An Exploratory Clinical Study of YTS109 Cell for R/R Autoimmune DiseasesRecruitingNCT07236762Phase 1
- A Study of CD19 UCAR-T Cells in Subjects With Autoimmune DiseasesNot yet recruitingNCT07212322Not applicable
- Exosomes in Patients With Ocular Involvement of Sjögren's SyndromeNot yet recruitingNCT07192666Early Phase 1
- MSCohi-O Lenses for Ocular Involvement in Sjögren's SyndromeNot yet recruitingNCT07185139Early Phase 1
- Creating Health Course Study for People With Rheumatological Conditions and Mood DisordersRecruitingNCT07180537Not applicable
- TREATMENT OF VAGINAL DRYNESS IN SJÖGREN'S DISEASE WITH CO2-LASER VERSUS TOPICAL PROMESTRIENERecruitingNCT07153276Phase 4
- A PHASE II PROSPECTIVE RANDOMIZED DOUBLE-MASKED CONTROLLED STUDY ASSESSING THE SAFETY & EFFICACY OF RHPRG4 (450 µG/ML RECOMBINANT HUMAN PROTEOGLYCAN 4) COMPARED TO VEHICLE FOR THE TREATMENT OF SJÖGREN'S RELATED DRY EYE DISEASERecruitingNCT07118241Phase 2
- Analyse of Inflammatory Activity of Sjögren's Syndrome on 68Ga-FAPI PET-CTRecruitingNCT07062523Phase 1/2
- A Study of CLN-978, a Subcutaneously Administered CD19-directed T Cell Engager, in Subjects With Sjogren's DiseaseRecruitingNCT07041099Phase 1
- AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.RecruitingNCT06991114Phase 2
- "Core Stabilization Strenght and Pelvic Floor Functions in Primary Sjogren's"Enrolling by invitationNCT06879444
- Fatigue in Sjögren's Syndrome: 3 Therapeutic StrategiesRecruitingNCT06875102Not applicable
- Therapeutic Effect of Upadacitinib in Primary Sjögren's SyndromeNot yet recruitingNCT06862284Phase 2
- Effects of Phytocannabinoids on Immune Response and Autophagy During Chronic Immune-mediated Inflammatory DiseasesRecruitingNCT06842316
- Safety and Efficacy of Universal CD19-targeting CAR-γδT Cells in Refractory Autoimmune DiseasesRecruitingNCT06828042Phase 1/2
- Safety and Efficacy of Universal CAR-T Cells (UWD-CD19) Combined With Immunosuppressants in the Treatment of Refractory Autoimmune DiseasesNot yet recruitingNCT06821659Phase 1/2
- Intraglandular Treatment with Adipose-derived Mesenchymal Stem Cells in Patients with Xerostomia Due to Sjögren's DiseaseRecruitingNCT06805448Phase 1/2
- BCMA-CD19 CAR-T Therapy for Refractory Autoimmune DiseasesRecruitingNCT06794008Phase 2
- Laser Acupuncture on Dry Eye and Sjögren's Syndrome-related Dry Eye Symptoms (LADESJS)RecruitingNCT06780293Phase 2
- Exosomes Proteomic for Sjogren's Syndrome and Dry Eye SyndromeRecruitingNCT06771427
- A Long-term Extension Study of Dazodalibep in Participants With Sjögren's Syndrome (SS)RecruitingNCT06747949Phase 3
- Home Based Clinical Management of Interstitial Lung Disease in Systemic Rheumatic DiseasesRecruitingNCT06732674Not applicable
- Ultrasonic COmparison of Salivary Glands in Autoimmune Diseases (COUGAR)Not yet recruitingNCT06680310
- Rare AutoImmune SElf-management Programme DevelopmentRecruitingNCT06642870
- ROLE of PLATELETS in the PATHOPHYSIOLOGY of SYSTEMIC LUPUSRecruitingNCT06593041
- Quest to Analyze One Thousand Humans MeditatingEnrolling by invitationNCT06583395
- Clinical Study on Targeted CD19 or CD19-BCMA CAR-T Therapy for Autoimmune DiseasesRecruitingNCT06548607Early Phase 1
- Functional Analysis of Salivary Glands and Correlation With Sialoscintigraphy in Sjogren's SyndromeRecruitingNCT06536075Not applicable
- Diagnostic Interest of the Buccal Schirmer Test in Xerostomia During Sjögren's Syndrome: XERODIAGNot yet recruitingNCT06530940
- Study on Optimization and Evaluation of Integrated Chinese and Western Medicine for pSS Glandular DamageEnrolling by invitationNCT06519617Phase 2
- Exosome-miRNA and Transcriptome Profiling of Dry Eye Syndrome and Sjogren's SyndromeNot yet recruitingNCT06475027
- Histopathological Analysis Versus Full-field Optical Coherence Tomography of Minor Salivary Gland Biopsy in Suspect Sjogren SyndromeRecruitingNCT06454370
- Sequential CAR-T Cells Targeting BCMA/CD19 in Patients With Relapsed/ Refractory Autoimmune DiseasesRecruitingNCT06428188Phase 1/2
- The Safety and Efficacy of Anti-CD19 CAR-T Cells in Patients With Relapsed/Refractory Autoimmune DiseasesNot yet recruitingNCT06420154Early Phase 1
- Preliminary Clinical Study of UTAA09 Injection in the Treatment of Relapsed/Refractory Autoimmune DiseasesNot yet recruitingNCT06417398Early Phase 1
- Belimumab After Rituximab in Resistant Primary Juvenile SSRecruitingNCT06410833Phase 4
- Salivary Conductivity Screening for Dry Eye Disease and Sjögren's SyndromeRecruitingNCT06406933
- Reliability, Validity, and Responsiveness of the Turkish Version of Eating Assessment Tool-10 for Patients With Primer Sjögren's SyndromeRecruitingNCT06401811
- Dose-Escalation Trial of Mesenchymal Stromal Cells in Patients With Medical XerostomiaRecruitingNCT06392711Phase 1
- An Clinical Study of YTS109 Cell Injection in Subjects With Recurrent/Refractory Autoimmune DiseaseRecruitingNCT06379646Not applicable
- Anti-CD19-CD3E-CAR-T Cells in Relapsed/Refractory Autoimmune DiseaseRecruitingNCT06373081Not applicable
- Early Clinical Study of UTAA09 Injection in the Treatment of Relapsed/Refractory Autoimmune DiseasesRecruitingNCT06361745Not applicable
- Fourth-gen CAR T Cells Targeting BCMA/CD19 for Refractory Systemic Lupus Erythematosus (SLE)RecruitingNCT06350110Phase 1/2
- Rheumatology Diet StudyRecruitingNCT06339957
- Ultra-High Frequency Ultrasonography in Sjögren's SyndromeRecruitingNCT06338735Not applicable
- Prevalence of Pre-clinical Sjögren Disease and Other Immune Disturbances in Subjects With Autoimmune Thyroiditis DiseaseRecruitingNCT06324578
- EVADRY® in the Treatment of Xerostomia in Sjögren's SyndromeNot yet recruitingNCT06313905Not applicable
- R-2487 in Patients With Sjogren's Syndrome (SS)Not yet recruitingNCT06297213Phase 1
- Safety and Efficacy of CD19 Targeted CAR-T Therapy for Refractory Autoimmune DiseaseRecruitingNCT06056921Phase 1
- 68Ga-P16-093 PET/CT Imaging in the Salivary GlandNot yet recruitingNCT06049368Phase 1/2
- Fetal-Hope Study: Home Monitoring of Fetal Heart Rate in SSA+ Pregnant WomenRecruitingNCT05958446
- Assessment of Physician Consideration of EPRO's, from Patients with Gout, Rheumatoid Arthritis, Sjogren's Syndrome or Systemic Lupus, on the Frequency of Therapeutic AdjustmentsRecruitingNCT05927688
- Armenian NAtionwide REGistry of Systemic Autoimmune and Autoinflammatory DiseasesRecruitingNCT05904301
- Universal CAR-T Cells (BRL-301) in Relapse or Refractory Autoimmune DiseasesEnrolling by invitationNCT05859997Not applicable
- Ultrasound Characteristics of the Salivary Glands in Patients With Rheumatoid ArthritisRecruitingNCT05782049Not applicable
- Clinical Cohort Study in Patients With Different Subtypes of Primary Sjogren Syndrome Related Dry EyeRecruitingNCT05605314
- New Clinical End-points in Patients With Primary Sjögren's SyndromeRecruitingNCT05113004Phase 2
- Penn SICCA Follow-up StudyNot yet recruitingNCT05056012
- The Efficacy and Safety of Iguratimod (IGU) in the Treatment of Primary Sjögren's SyndromeRecruitingNCT04981145Phase 4
- B-dependant Rare AutoImmune diseaSES - Cohort of Patients With Suspected Diagnosis of Primitive Sjögren SyndromeRecruitingNCT04931160Not applicable
- Dental and Periodontal Status of Patients With Sjögren's Syndrome.RecruitingNCT04848870
- Rheumatology Patient Registry and BiorepositoryRecruitingNCT04402086
- Dry Eye Syndrome, Healthy Control, Sjögren's Syndrome and Other Inflammation Disease in Taiwan BiobankNot yet recruitingNCT03938207
- Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVORecruitingNCT03816345Phase 1
- Diagnostic Suspicion of Primitive Syndrome Sjögren's : Brest CohortRecruitingNCT03681964
- Meir Medical Center Rheumatologic BiobankRecruitingNCT03473912
- Maternal Autoimmune Disease Research Alliance (MADRA) RegistryRecruitingNCT03276923
- The Myelin Disorders Biorepository ProjectRecruitingNCT03047369